Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
Mon Compte
No element in selection

Favoris
Établissements de santé
Contact Abonnez-vous aux actualités

0 result

Active substance : clopidogrel
Topics : Diseases and conditions
Topics : Quality of care and patient safety

Topic

Diseases and conditions (2)
Plus ...
Quality of care and patient safety (2)
Plus ...
Diagnostic and therapeutic techniques (1)
Plus ...
- Surgical procedures (1)
- Plus ...
  - Oromaxillofacial surgery (1)

Drugs, devices and medical acts (1)
Plus ...
- Health technology assessment (1)
Articles and news (1)
Plus ...
- Web page (1)

Date

This year (1)

industriels (1)

Français (2)

Active substance

abatacept (1)
acide clavulanique (1)
acide tranexamique (1)
alcool (2)
amoxicilline (1)
anakinra (1)
aspirine (1)
azathioprine (1)
canakinumab (1)
chrome (1)
ciclosporine (1)
ciprofloxacine (1)
clarithromycine (1)
clindamycine (1)
clopidogrel (2)
cobalt (1)
fluindione (1)
ivabradine (1)
lithium (1)
morphine (1)
nicotine (1)
potassium (1)
prasugrel (2)
prednisone (1)
pristinamycine (1)
rituximab (1)
rivaroxaban (1)
sirolimus (1)
tacrolimus (1)
tocilizumab (1)

More filter Other Filter Icon

Other Filter Icon

Search Export

Follow us :

Advancing quality in the fields of health and social care services

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

4uj1595P6zVgUuC7